ARK Genomic Revolution ETF vs Lowe`s Companies Inc — how do they compare? ARK Genomic Revolution ETF trades at $44.49, while Lowe`s Companies Inc trades at $221.22 (market cap $124.06B). The key difference: Lowe`s Companies Inc pays a 2.26% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Lowe`s Companies Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | LOW | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $44.55 | $287.39 |
52-Week Low | $24.02 | $201.92 |
Market Cap | — | $124.06B |
Enterprise Value | — | $165.81B |
Dividend Yield | — | 2.26% |
Trailing returns across standard periods
Latest headlines on both assets
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Lowe's is the second-largest home improvement retailer in the world, operating 1,969 stores and servicing around 230 dealer-owned stores throughout the United States and Canada. The firm's stores offer products and services for home decorating, maintenance, repair, and remodeling, with maintenance and repair accounting for two thirds of products sold. Lowe's targets retail do-it-yourself (around 75% of sales) and do-it-for-me customers as well as commercial and professional business clients (around 25% of sales). We estimate Lowe's captures a low-double-digit share of the domestic home improvement market, based on U.S. Census data and management's estimates for market size.
Read more on LOW →